Group One Trading’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $146K | Buy |
+4,653
| New | +$146K | ﹤0.01% | 996 |
|
2025
Q1 | – | Hold |
0
| – | – | – | 3672 |
|
2024
Q4 | – | Sell |
-104
| Closed | -$4.09K | – | 3517 |
|
2024
Q3 | $4.09K | Buy |
104
+100
| +2,500% | +$3.94K | ﹤0.01% | 1382 |
|
2024
Q2 | $156 | Buy |
+4
| New | +$156 | ﹤0.01% | 1637 |
|
2024
Q1 | – | Hold |
0
| – | – | – | 3337 |
|
2023
Q4 | – | Sell |
-8,005
| Closed | -$273K | – | 3431 |
|
2023
Q3 | $273K | Buy |
+8,005
| New | +$273K | ﹤0.01% | 667 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 3415 |
|
2023
Q1 | – | Sell |
-6,552
| Closed | -$258K | – | 3303 |
|
2022
Q4 | $258K | Sell |
6,552
-5,021
| -43% | -$198K | ﹤0.01% | 681 |
|
2022
Q3 | $418K | Buy |
11,573
+2,813
| +32% | +$102K | ﹤0.01% | 617 |
|
2022
Q2 | $266K | Buy |
8,760
+4,153
| +90% | +$126K | ﹤0.01% | 788 |
|
2022
Q1 | $141K | Buy |
+4,607
| New | +$141K | ﹤0.01% | 1139 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 3387 |
|
2021
Q3 | – | Sell |
-890
| Closed | -$17K | – | 3289 |
|
2021
Q2 | $17K | Buy |
+890
| New | +$17K | ﹤0.01% | 1707 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 2958 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 2250 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 2238 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 2213 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 2133 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 2082 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 2125 |
|